This article is maintained by: Elsevier
Article Title: Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study
Journal Title: The Lancet Infectious Diseases
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1473-3099(17)30235-9
CrossRef DOI link to the associated document: https://doi.org/10.1016/S1473-3099(17)30237-2
Content Type: article
Copyright: © 2017 The Author(s). Published by Elsevier Ltd.